Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurochem ; 130(6): 770-9, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24903676

ABSTRACT

In the present study, the effects of the two classical anti-epileptic drugs, carbamazepine and valproic acid, and the non-classical anti-seizure drug vinpocetine were investigated on the expression of the pro-inflammatory cytokines IL-1ß and TNF-α in the hippocampus of rats by PCR or western blot after the administration of one or seven doses. Next, the effects of the anti-seizure drugs were investigated on the rise in cytokine expression induced by lipopolysaccharides (LPS) inoculation in vivo. To validate our methods, the changes induced by the pro-convulsive agents 4-aminopyridine, pentylenetetrazole and pilocarpine were also tested. Finally, the effect of the anti-seizure drugs on seizures and on the concomitant rise in pro-inflammatory cytokine expression induced by 4-aminopyridine was explored. Results show that vinpocetine and carbamazepine reduced the expression of IL-1ß and TNF-α from basal conditions, and the increase in both pro-inflammatory cytokines induced by LPS. In contrast, valproic acid failed to reduce both the expression of the cytokines from basal conditions and the rise in IL-1ß and TNF-α expression induced by LPS. Tonic-clonic seizures induced either by 4-aminopyridine, pentylenetetrazole or pilocarpine increased the expression of IL-1ß and TNF-α markedly. 4-aminopyridine-induced changes were reduced by all the tested anti-seizure drugs, although valproic acid was less effective. We conclude that the anti-seizure drugs, vinpocetine and carbamazepine, whose mechanisms of action involve a decrease in ion channels permeability, also reduce cerebral inflammation. The mechanism of action of anti-seizure drugs like vinpocetine and carbamazepine involves a decrease in Na(+) channels permeability. We here propose that this mechanism of action also involves a decrease in cerebral inflammation.


Subject(s)
Anticonvulsants/pharmacology , Carbamazepine/pharmacology , Hippocampus/metabolism , Interleukin-1beta/biosynthesis , Tumor Necrosis Factor-alpha/biosynthesis , Valproic Acid/pharmacology , Vinca Alkaloids/pharmacology , 4-Aminopyridine/antagonists & inhibitors , 4-Aminopyridine/pharmacology , Animals , Behavior, Animal/drug effects , Blotting, Western , Convulsants/pharmacology , DNA, Complementary/biosynthesis , DNA, Complementary/genetics , Epilepsy, Tonic-Clonic/chemically induced , Epilepsy, Tonic-Clonic/physiopathology , Hippocampus/drug effects , Interleukin-1beta/antagonists & inhibitors , Lipopolysaccharides/pharmacology , Male , Polymerase Chain Reaction , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...